Cargando…
TFCP2 Overcomes Senescence by Cooperating With SREBP2 to Activate Cholesterol Synthesis in Pancreatic Cancer
KRAS mutation is very common in pancreatic cancer. How pancreatic cancer cells overcome oncogene-induced senescence is not fully understood. Our previous studies showed that up-regulation of TFCP2 (transcription factor CP2) in pancreatic cancer promoted the growth and metastasis of pancreatic cancer...
Autores principales: | Zhang, Dexiang, Lu, Pinxiang, Zhu, Kaihua, Wu, Haixia, Dai, Yuedi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599447/ https://www.ncbi.nlm.nih.gov/pubmed/34804919 http://dx.doi.org/10.3389/fonc.2021.724437 |
Ejemplares similares
-
TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer
por: Yuedi, Dai, et al.
Publicado: (2017) -
Neglected Functions of TFCP2/TFCP2L1/UBP1 Transcription Factors May Offer Valuable Insights into Their Mechanisms of Action
por: Taracha, Agnieszka, et al.
Publicado: (2018) -
A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP‐2
por: Li, Yujie, et al.
Publicado: (2017) -
Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling
por: Tang, Hong, et al.
Publicado: (2016) -
Transcription factor LSF (TFCP2) inhibits melanoma growth
por: Goto, Yuji, et al.
Publicado: (2015)